Liu, J.; Liu, Z.; Zhang, J.; Chen, X.; Chen, J.; Sui, L.; Yu, J.
Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner. Pharmaceutics 2022, 14, 1876.
https://doi.org/10.3390/pharmaceutics14091876
AMA Style
Liu J, Liu Z, Zhang J, Chen X, Chen J, Sui L, Yu J.
Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner. Pharmaceutics. 2022; 14(9):1876.
https://doi.org/10.3390/pharmaceutics14091876
Chicago/Turabian Style
Liu, Jia, Zhuojun Liu, Jing Zhang, Xiaofang Chen, Junge Chen, Linlin Sui, and Jian Yu.
2022. "Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner" Pharmaceutics 14, no. 9: 1876.
https://doi.org/10.3390/pharmaceutics14091876
APA Style
Liu, J., Liu, Z., Zhang, J., Chen, X., Chen, J., Sui, L., & Yu, J.
(2022). Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner. Pharmaceutics, 14(9), 1876.
https://doi.org/10.3390/pharmaceutics14091876